Asano Y - Search Results

1

Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.

Ihn H, Yamane K, Asano Y, Jinnin M, Tamaki K. Ihn H, et al. Among authors: asano y. Rheumatology (Oxford). 2006 Feb;45(2):157-65. doi: 10.1093/rheumatology/kei124. Epub 2005 Nov 30. Rheumatology (Oxford). 2006. PMID: 16319104

2

Clinical and laboratory features of scleroderma patients with pulmonary hypertension.

Yamane K, Ihn H, Asano Y, Yazawa N, Kubo M, Kikuchi K, Soma Y, Tamaki K. Yamane K, et al. Among authors: asano y. Rheumatology (Oxford). 2000 Nov;39(11):1269-71. doi: 10.1093/rheumatology/39.11.1269. Rheumatology (Oxford). 2000. PMID: 11085808

3

Antibodies to Th/To ribonucleoprotein in patients with localized scleroderma.

Yamane K, Ihn H, Kubo M, Kuwana M, Asano Y, Yazawa N, Tamaki K. Yamane K, et al. Among authors: asano y. Rheumatology (Oxford). 2001 Jun;40(6):683-6. doi: 10.1093/rheumatology/40.6.683. Rheumatology (Oxford). 2001. PMID: 11426027

4

Anti-U5 snRNP antibody as a possible serological marker for scleroderma-polymyositis overlap.

Kubo M, Ihn H, Kuwana M, Asano Y, Tamaki T, Yamane K, Tamaki K. Kubo M, et al. Among authors: asano y. Rheumatology (Oxford). 2002 May;41(5):531-4. doi: 10.1093/rheumatology/41.5.531. Rheumatology (Oxford). 2002. PMID: 12011376

5

Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease.

Ihn H, Asano Y, Kubo M, Yamane K, Jinnin M, Yazawa N, Fujimoto M, Tamaki K. Ihn H, et al. Among authors: asano y. Rheumatology (Oxford). 2002 Nov;41(11):1268-72. doi: 10.1093/rheumatology/41.11.1268. Rheumatology (Oxford). 2002. PMID: 12421999

6

Plasma plasmin-alpha2-plasmin inhibitor complex levels are increased in systemic sclerosis patients with pulmonary hypertension.

Jinnin M, Ihn H, Yamane K, Asano Y, Yazawa N, Tamaki K. Jinnin M, et al. Among authors: asano y. Rheumatology (Oxford). 2003 Feb;42(2):240-3. doi: 10.1093/rheumatology/keg071. Rheumatology (Oxford). 2003. PMID: 12595617

7

Clinical features of patients with systemic sclerosis accompanied by rheumatoid arthritis.

Jinnin M, Ihn H, Yamane K, Asano Y, Yazawa N, Tamaki K. Jinnin M, et al. Among authors: asano y. Clin Exp Rheumatol. 2003 Jan-Feb;21(1):91-4. Clin Exp Rheumatol. 2003. PMID: 12673896

8

Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis.

Asano Y, Ihn H, Kubo M, Jinnin M, Mimura Y, Ashida R, Tamaki K. Asano Y, et al. Rheumatology (Oxford). 2006 Mar;45(3):303-7. doi: 10.1093/rheumatology/kei143. Epub 2005 Nov 8. Rheumatology (Oxford). 2006. PMID: 16278285

9

Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.

Asano Y, Ihn H, Yamane K, Yazawa N, Kubo M, Fujimoto M, Tamaki K. Asano Y, et al. Arthritis Rheum. 2001 Jun;44(6):1363-9. doi: 10.1002/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5. Arthritis Rheum. 2001. PMID: 11407696 Free article.

10

Anti-U1RNP antibodies in patients with localized scieroderma.

Yamane K, Ihn H, Kubo M, Kuwana M, Asano Y, Yazawa N, Tamaki K. Yamane K, et al. Among authors: asano y. Arch Dermatol Res. 2001 Sep;293(9):455-9. doi: 10.1007/s004030100254. Arch Dermatol Res. 2001. PMID: 11758788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,542 results

Search Page

Filters